CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanghai Fosun Pharmaceutical (Group) Company Limited Company Snapshot
Shanghai Fosun Pharmaceutical (Group) Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Fosun Pharmaceutical (Group) Company Limited with three other companies in this sector in China: Shenzhen Neptunus Bioengineer (2015 sales of 11.12 billion Chinese Renmimbi [US$1.63 billion] of which 85% was Pharmaceutical Distribution), Tasly Pharmaceutical Group Company Limited (13.22 billion Chinese Renmimbi [US$1.93 billion] of which 51% was Medicine Commerce), and Shandong Buchang Pharmaceuticals Co Ltd (11.65 billion Chinese Renmimbi [US$1.70 billion] of which 88% was Pharmaceutical Business).

Sales Analysis. During the year ended December of 2015, sales at Shanghai Fosun Pharmaceutical (Group) Company Limited were 12.50 billion Chinese Renmimbi (US$1.83 billion). This is an increase of 4.7% versus 2014, when the company's sales were 11.94 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shanghai Fosun Pharmaceutical (Group) Company Limited (and since 2010, sales have increased a total of 175%). Sales of Other Business Operations saw an increase that was more than double the company's growth rate: sales were up 163.7% in 2015, from 14.33 million Chinese Renmimbi to 37.78 million Chinese Renmimbi. Shanghai Fosun Pharmaceutical (Group) Company Limited also saw significant increases in sales in Pharmaceutical Manufacturing and R&d (up 21.7% to 8.84 billion Chinese Renmimbi) and Medical Diagnosis and Medical Devices (up 16.2% to 2.24 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Fosun Pharmaceutical (Group) Company Limited
  Stock Performance Chart for Shanghai Fosun Pharmaceutical (Group) Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 24.86
(Figures in Chinese Renmimbi)
1 Week 4.6%   13 Weeks 10.5%  
4 Weeks 7.0%   52 Weeks 34.7%  
 
Shanghai Fosun Pharmaceutical (Group) Company Limited Key Data:
  Ticker: 600196 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 12,502,163,000
(Year Ending Jan 2016).
Employees: 17,842
  Currency: Chinese Renmimbi Market Cap: 57,527,904,500
  Fiscal Yr Ends: December Shares Outstanding: 2,314,075,000
  Share Type: A Gu Closely Held Shares: 981,726,689
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.